Related by context. All words. (Click for frequent words.) 59 hypovolemia 59 left ventricular diastolic 59 hypoperfusion 59 autoregulation 59 prolonged QT interval 59 myocardial reperfusion 58 inotropic 58 dose proportional pharmacokinetics 58 neurosensory 58 neuroleptic 58 hMG 58 electroencephalographic 58 neurologic symptoms 58 hematological parameters 58 Tasigna prolongs 58 vitamin B# folic acid 57 cystoscopic 57 vasodilatation 57 hepatic lesions 57 hyperalgesia 57 QTc intervals 57 K ras mutations 57 radiographic findings 57 luteal 57 subconjunctival hemorrhage 57 metabolite concentrations 57 torsade de pointes 57 hemodilution 57 syncope fainting 57 morphometric vertebral fractures 57 transaminase elevations 57 EEG abnormalities 57 sonographically 57 Hypotension 57 hypothalamic pituitary adrenal axis 57 serum PTH 56 hamartomas 56 ictal 56 pituitary hormone 56 neuropsychological impairments 56 β blockers 56 ultrasonographic 56 triiodothyronine 56 intravascular hemolysis 56 afterload 56 coagulation parameters 56 primidone 56 myocyte 56 brain lesions 56 hypothalamic pituitary 56 cortical activation 56 thyroglobulin 56 Heavy menstrual bleeding 56 biphasic 56 pulsatility 56 Chronic pancreatitis 56 biochemical abnormalities 56 intraventricular 56 transabdominal 56 symptomatic VTE 56 virologic breakthrough 56 endometrial biopsy 56 conditional logistic regression 56 neuropsychiatric symptoms 56 liver steatosis 56 cranial irradiation 56 electrophysiologic 56 corpus luteum 56 gastro oesophageal reflux 56 neurocognitive deficits 56 intracerebral haemorrhage 56 tumor regressions 56 paracentesis 56 SIADH 55 Kaplan Meier curve 55 natriuresis 55 cerebral angiography 55 upper GI tract 55 esophageal reflux 55 postoperative complication 55 virological response 55 akinesia 55 Multivariate logistic regression 55 locomotor activity 55 vascular dysfunction 55 amyloid deposition 55 angiographically 55 tegaserod 55 hemorrhagic complications 55 TNFalpha 55 anterior temporal 55 EEG recordings 55 neurologic abnormalities 55 Thyroid hormone 55 lymphocyte counts 55 scintigraphic 55 rCBF 55 gastric distention 55 mdx mice 55 T2 lesions 55 urodynamic 55 Febrile neutropenia 55 histopathologic findings 55 alkalosis 55 QTc 55 pressure natriuresis 55 Erythropoietic therapies may 55 ecchymosis 55 #F FDG PET 55 Thrombotic thromboembolic complications 55 QTc prolongation 55 extrapyramidal symptoms 55 cardioprotection 55 levodopa therapy 55 ICD shocks 55 estrogen deficiency 55 ischaemia 55 metaplasia 55 overt hypothyroidism 55 chest radiographs 55 behavioral abnormalities 55 plasma creatinine 55 DNA demethylation 55 peri procedural 55 abrupt discontinuation 55 hematologic parameters 55 oral anticoagulation 55 electrical cardioversion 55 timepoints 55 cutaneous lesions 55 malperfusion 55 cerebral ischemia 55 hypoxemia 55 perfusion MRI 55 nausea constipation 55 autonomic dysfunction 55 neuropathologic 55 transfusion syndrome 55 aspartate aminotransferase AST 55 akinetic mutism 55 immunohistochemical 54 antiplatelet medications 54 menstrual bleeding 54 myopathy rhabdomyolysis 54 cervical secretions 54 nitrotyrosine 54 aromatase inhibitor therapy 54 intima media thickness 54 serum lipid 54 NUCYNTA R 54 clinically meaningful reductions 54 ventricular enlargement 54 meta regression 54 myocardial dysfunction 54 Postoperative complications 54 pyridostigmine 54 analgesic medications 54 infantile hemangioma 54 posterior cingulate 54 circadian misalignment 54 chromosomal aberrations 54 plasma lipids 54 cortisol secretion 54 anticonvulsant medication 54 systolic function 54 genotypic resistance 54 diffusion tensor 54 haematologic 54 Cardiorespiratory fitness 54 vasospasm 54 myoclonus 54 dose titration 54 Venous thromboembolism 54 airway hyperresponsiveness 54 acute decompensation 54 thyrotoxicosis 54 GH secretion 54 Pharmacokinetic studies 54 hepatic function 54 primary aldosteronism 54 amenorrhea 54 hyperarousal 54 poststroke 54 Retrograde ejaculation 54 prefrontal regions 54 multiple logistic regression 54 ovarian hormones 54 HER2 overexpression 54 corrected QT interval 54 dysrhythmias 54 urethral strictures 54 postoperative AF 54 cervicitis 54 recurrent miscarriage 54 neuropathological 54 aminotransferases 54 GH IGF 54 perioperative complications 54 radiographic outcomes 54 cardiac repolarization 54 VCUG 54 TGF beta signaling 54 coronary occlusion 54 brain neurochemistry 54 HPA axis 54 abdominal distension 54 posterior vitreous detachment 54 DCE MRI 54 adrenal function 54 capillary leakage 54 maturational 54 Daytime sleepiness 54 PLMs 54 potentiation 54 neurologic deficits 54 bi phasic 54 antiplatelet therapies 54 premenstrual syndrome PMS 54 artery stenosis 54 CT perfusion 54 IV bisphosphonates 54 OSAHS 54 perfusion defects 54 serum estradiol 54 colonoscopic 54 imatinib resistance 54 haemodynamic 54 microcirculatory 54 CYP #A# 53 neuroimaging studies 53 osteoid 53 adrenocorticotropic hormone 53 spirometric 53 variant angina 53 lumbar disk herniation 53 hyperreflexia 53 sacral neuromodulation 53 Pharmacokinetic parameters 53 gut motility 53 Doppler sonography 53 liver histology 53 calculated creatinine clearance 53 Postoperatively 53 FFR measurements 53 torsades de pointes 53 color Doppler sonography 53 PLX STROKE targeting 53 acetabular dysplasia 53 antiphospholipid antibodies 53 timepoint 53 Multiple logistic regression 53 multivariate logistic regression 53 covariate 53 hypometabolism 53 coagulopathy 53 carotid IMT 53 Multivariable logistic regression 53 thrombus formation 53 dopaminergic therapy 53 rFSH 53 systemic corticosteroid 53 syncopal episode 53 p# activation 53 carcinoids 53 hypercapnia 53 hemodynamic parameters 53 repetitive transcranial magnetic stimulation 53 neuropsychological assessment 53 stratifying patients 53 poststroke depression 53 Symptom severity 53 vasomotor symptoms 53 PSA kinetics 53 brainwave patterns 53 neurologic dysfunction 53 contractile function 53 platelet reactivity 53 neuronal dysfunction 53 status epilepticus 53 leiomyoma 53 histologic findings 53 transcranial Doppler 53 intermittent hypoxia 53 adrenocortical 53 glycogen metabolism 53 plasma pharmacokinetics 53 hippocampal atrophy 53 Thyroxine 53 QTcF 53 Oral corticosteroids 53 preterm neonates 53 biliary obstruction 53 Hematologic toxicity 53 vessel dilation 53 hormone secretion 53 symptomatic hyponatremia 53 experimentally induced 53 abnormal vaginal bleeding 53 metaanalysis 53 Meta analyzes 53 Zevalin consolidation 53 gene rearrangements 53 Urge incontinence 53 RQ PCR 53 serum lipid levels 53 coagulation abnormalities 53 abnormal uterine bleeding 53 proton MR spectroscopy 53 pharmacodynamic parameters 53 antiangiogenic therapy 53 DHEA supplementation 53 penile erection 53 daytime alertness 53 ventricular dilation 53 physiologic parameters 53 hematological toxicity 53 duplex ultrasonography 53 lesional 53 QT intervals 53 PASI scores 53 bleedings 53 pharmacologic intervention 53 tonsillar hypertrophy 53 symptomatic pulmonary embolism 53 Postoperative 53 myocardial ischaemia 53 antidiabetic medications 53 glycated hemoglobin levels 53 intracranial stenosis 53 clefting 53 intestinal motility 53 photoactivation 53 denervation 53 Adverse effects 53 Skin sterol 53 VA# [002] 53 leiomyomas 53 frequent awakenings 53 choroidal neovascularization 53 aortic stiffness 53 baroreflex 53 TIMP 1 53 EKG electrocardiogram 53 transcranial Doppler ultrasound 53 bladder bowel 53 cerebrovascular events 53 Surgical excision 53 IL 1ß 53 strong CYP#A# inducers 53 dosing interval 53 paroxysmal AF 53 adjuvant systemic 53 metabolic acidosis 53 gross hematuria 53 gastro esophageal reflux 53 hyperglycaemia 53 HPA axis suppression 53 neurohormonal 53 XR NTX 52 choroidal neovascularization CNV 52 urodynamic studies 52 osteoblastic 52 surgical decompression 52 baroreceptor reflex 52 liver metastasis 52 perfusion abnormalities 52 splanchnic 52 isoenzyme 52 overactive bladder symptoms 52 myofibroblast 52 echocardiographic 52 apneic episodes 52 fatty infiltration 52 aneurysmal subarachnoid hemorrhage 52 leukocyte counts 52 cardiac magnetic resonance 52 acoustic startle 52 Mild hypothermia 52 carotid stenosis 52 Fetal heartbeats 52 lichen planus 52 Histologic 52 erythrocyte sedimentation rate 52 lordosis 52 CD#c 52 aortic regurgitation 52 carotid artery blockage 52 ischemia induced 52 adrenalectomy 52 tenderness clinical mastalgia 52 gliosis 52 umbilical artery 52 mu opioid agonists 52 serum concentrations 52 jugular venous 52 spontaneous regression 52 euthymic patients 52 mania hypomania 52 bradykinesia 52 LYSTEDA 52 tamponade 52 chlamydial infection 52 Calcium intake 52 exogenous insulin 52 multivariate analyzes 52 anticholinergic medication 52 placental function 52 intracranial hypertension 52 Chlamydia trachomatis infection 52 nonalcoholic steatohepatitis NASH 52 metabolic abnormalities 52 UPDRS scores 52 coexpression 52 Estradiol 52 systemic immunosuppressive 52 anticholinergic medications 52 plasminogen activators 52 linear pharmacokinetics 52 de novo mutations 52 placental tissues 52 neuritic 52 neuronal plasticity 52 serum leptin 52 zebrafish larvae 52 hippocampal neurons 52 saccades 52 LPS induced 52 electrostimulation 52 IM progesterone 52 cardiac autonomic 52 antiepileptic medications 52 coronary revascularization procedures 52 transgene expression 52 allopregnanolone 52 ECLS 52 constipation nausea 52 cellular prion protein 52 sequela 52 parasomnias 52 anti androgen 52 arteriography 52 ECG abnormalities 52 hematopoietic cancers 52 amenorrhoea 52 eosinophilia 52 epidural analgesia 52 pleiotropic effects 52 theta rhythm 52 hyperexcitability 52 premenopause 52 pentoxifylline 52 estimated GFR 52 synthetic progestin 52 neurodevelopmental outcome 52 synovial fibroblasts 52 Skin lesions 52 HbF 52 ventricular tachyarrhythmia 52 noninvasive technique 52 overnight polysomnography 52 MDCT angiography 52 postoperative morbidity 52 myometrium 52 breast abscesses 52 Color Doppler 52 endometrial hyperplasia 52 abdominal ultrasound 52 DNA methylation patterns 52 conventional angiography 52 Vaginal dryness 52 inactivated influenza vaccines 52 antral 52 neurohormones 52 SpO 2 52 intra ocular pressure 52 aminotransferase levels 52 organ perfusion 52 multivariate adjustment 52 GnRH agonist 52 somatosensory evoked potentials 52 tumor histology 52 dermatologic reactions 52 tumor perfusion 52 chromosomal rearrangement 52 Diabetic neuropathy 52 Index CDAI 52 β cell 52 NMIBC 52 diastole 52 dysmenorrhoea 52 computed tomographic 52 Exclusion criteria 52 nonfasting triglyceride levels 52 exploratory endpoints 52 tracheal intubation 52 hemodynamic instability 52 embryonic lethality 52 polyuria 52 univariate 52 hemoptysis 52 liver biopsies 52 dyspareunia 52 endometrial thickness 52 quantitative EEG 52 papilledema 52 imatinib therapy 52 procalcitonin 52 sentinel lymph node biopsy 52 aortic calcification 52 symptomology 52 headache nausea fatigue 52 elevated creatinine 52 coronary calcification 52 periprocedural 52 agonist antagonist 52 neurocognitive function 52 transesophageal echocardiography 52 hyperactivation 52 posttreatment 52 etiologic 52 teratogens 52 hyperammonemia 52 luteal phase 52 unmeasured confounders 52 impaired cognition 52 corneal astigmatism 52 salivary cortisol 52 Bacterial vaginosis 52 nonpharmacologic 51 affective psychosis 51 Post operatively 51 QT prolongation 51 aetiological 51 histopathologic 51 surgical debulking 51 creatine supplementation 51 rebleeding 51 Cytogenetic 51 adrenal cortex 51 endometrial carcinoma 51 intratumoral 51 postoperative pulmonary 51 allogeneic HSCT 51 psychosocial variables 51 dopamine antagonists 51 inflammatory lesions 51 rhythm disturbances 51 neural degeneration 51 cortical regions 51 pathologic fractures 51 focally 51 SLNB 51 enzyme immunoassay EIA 51 atherothrombotic 51 OAB symptoms 51 effector functions 51 perioperative morbidity 51 photosensitizing agent 51 detrusor 51 distensibility 51 lymphopenia 51 JAK STAT signaling 51 lipid profiles 51 SCr 51 polysomnographic 51 glaucomatous 51 laser photocoagulation 51 Intussusception 51 endocannabinoid signaling 51 impair fertility 51 CKD MBD 51 Bispectral Index 51 hypomanic episodes 51 pleiotropy 51 nerve conduction velocity 51 GnRH antagonist 51 venography 51 airflow obstruction 51 desaturation 51 osteogenic differentiation 51 metabolic dysfunction 51 clinicopathologic 51 chromosomal mutations 51 relapsed MCL 51 multivariate Cox 51 T1DM 51 hsCRP levels 51 Genetic mutation 51 Viral load 51 vermis 51 myalgias 51 gamma oscillations 51 intraobserver 51 biochemical markers 51 airway reactivity 51 dizziness headache nausea 51 FDG uptake 51 parkinsonian symptoms 51 Hemodynamic 51 Immunohistochemical analysis 51 abnormal clotting 51 immunostaining 51 PCWP 51 neuroleptics 51 corneal neovascularization 51 serum bicarbonate 51 delayed gastric emptying 51 airflow limitation 51 wavefront guided LASIK 51 CIN3 51 electrolyte abnormalities 51 atherogenesis 51 Atypical antipsychotics 51 temporoparietal 51 hypoglycaemic episodes 51 elevated ALT 51 repolarization 51 neurocognitive impairment 51 atrioventricular 51 PCOD 51 thyroid stimulating hormone 51 pathophysiological mechanisms 51 apo B 51 hypothalamic pituitary gonadal HPG 51 Sociodemographic 51 diarrhea abdominal 51 prefrontal cortical 51 tardive dyskinesia TD 51 PER2 51 histologically 51 mitral stenosis 51 ventricular arrhythmia 51 interobserver 51 Menstrual cramps 51 recurrent venous thromboembolism 51 underlying pathophysiology 51 periprocedural MI 51 dexmedetomidine 51 fluoxetine Prozac 51 cerebral cortical 51 hyperemesis 51 uterine bleeding 51 Withdrawal symptoms 51 electromyographic EMG 51 ovulatory 51 corticosterone levels 51 hydrops 51 Thyroid disorders 51 hypoactive 51 lightheadedness dizziness 51 estrogen metabolites 51 ovulatory cycles 51 pelvic girdle pain 51 BPS IC 51 aspirin regimen 51 multivariate regression 51 diabetic kidney 51 S nitrosylation 51 nonallergic rhinitis 51 transient elastography 51 CR nPR 51 LV dysfunction 51 antioxidant supplementation 51 arterial stiffening 51 prostate carcinogenesis 51 Fluid retention 51 CORE OM 51 dentinal hypersensitivity 51 femoral neck fracture 51 distension 51 aMCI precursor 51 symptomatic paroxysmal AF 51 premorbid 51 clomipramine 51 immunological responses 51 varus deformity 51 anatomic structures 51 pathophysiologic 51 fetal malformations 51 thunderclap headache 51 electrophysiological 51 patellar dislocation 51 idiopathic scoliosis 51 atheroma volume 51 hepatic fibrosis 51 cardiac perfusion 51 Kaplan Meier analysis 51 neurologic outcomes 51 vasopressors 51 chronic periodontitis 51 esophagogastric 51 anti epileptics 51 conventional DMARDs 51 Electroencephalography 51 QTc interval 51 demonstrated clinically meaningful 51 anovulation 51 nerve degeneration 51 demethylation 51 NKT cell 51 spherical aberrations 51 doxorubicin HCl 51 neurological abnormalities 51 Electroconvulsive therapy 51 neuroregenerative 51 catheter insertions 51 esophageal manometry 51 cardiac dysfunction 51 neovascular 51 adrenal suppression 51 contrast induced nephropathy 51 diagnostically 51 Poisson regression 51 comorbid disorders 51 virologic responses 51 female hormones estrogen 51 inhaled bronchodilators 51 P = .# 51 hypothalamic pituitary axis 51 hematologic toxicity 51 transcranial 51 morphological abnormalities 51 genetic loci 51 Glucocorticoids 51 occipital regions 51 parkinsonism 51 cytologically 51 electro acupuncture 51 frameless radiosurgery 51 hyperinsulinemia 51 electroencephalograms 51 tachyarrhythmias 51 ispinesib administered 50 wavelet transform 50 Leydig cell 50 amyloid cascade 50 miRNA expression 50 subclinical inflammation 50 tiagabine 50 atherosclerotic lesion 50 glycosylated hemoglobin HbA1c 50 systolic dysfunction 50 vasomotor 50 dyskeratosis congenita 50 SRBD 50 PNES 50 stone formers 50 HIV RNA 50 hematological relapse 50 ductus venosus 50 CT urography 50 NMDAR 50 ERK activation 50 Cardiotoxicity 50 renal cysts 50 delusions hallucinations 50 Insulin sensitivity 50 echo planar 50 nighttime awakenings 50 myocytes 50 Febrile seizures 50 cortical thinning 50 ophthalmoscopy 50 T2DM 50 flow mediated dilation 50 pupillary 50 echogenic foci 50 Aeolus Pharmaceuticals Announces 50 cholinergic tone 50 Non inferiority 50 nasopharyngitis headache 50 malabsorptive 50 intact parathyroid hormone 50 psychotherapeutic interventions 50 glucocorticoid therapy 50 opioid naïve 50 vascular reactivity 50 receiving XGEVA 50 bone scintigraphy 50 dyssynchrony 50 IFN γ 50 nausea vomiting headache 50 azoospermia 50 circadian cycles 50 vertebral subluxation 50 androgen therapy 50 subthreshold 50 Ketosis 50 subclinical disease 50 densitometry 50 thyroid hormone deficiency 50 coronary artery dissection 50 psychiatric comorbidity 50 endogenous hormones 50 ALB # 50 Prostatitis 50 QT QTc 50 brachial artery flow 50 androgen deprivation 50 androgen ablation 50 neovascularization 50 somatoform disorders 50 GAMMAGARD 50 extreme dreaders 50 Pernicious anemia 50 functional neuroimaging 50 univariate analyzes 50 multiplanar 50 color Doppler 50 multi infarct dementia 50 PIB PET 50 Sgk1 50 clinically meaningful improvements 50 hyperprolactinemia 50 fibrotic disease 50 pelvic lymphadenectomy 50 LAB CGRP 50 predisposing factor 50 EDSS scores 50 post operatively 50 psychophysiological 50 mutated K ras 50 saccadic 50 prostate epithelial cells 50 menopausal hot flushes 50 PSADT 50 Excessive daytime sleepiness 50 inhaled corticosteroid therapy 50 glucocorticoid hormones 50 alanine aminotransferase ALT 50 NUCYNTA ™ 50 depressive symptomatology 50 multiple linear regression 50 monoamine oxidase inhibitors 50 mTOR signaling pathway 50 diplopia 50 thyroid hormone levels 50 methylation patterns 50 KCNH2 50 Myocardial infarction 50 parkinsonian 50 urolithiasis 50 serum CRP 50 untreated OSA 50 computerized tomography scan 50 thromboembolic complications 50 PECAM 1 50 immune reconstitution syndrome 50 abnormal heartbeats 50 recombinant FSH 50 Wernicke Korsakoff syndrome 50 hormonal milieu 50 planum temporale 50 multivariable analysis 50 pharmacologic treatments 50 CP CPPS 50 psychomotor agitation 50 Acute pancreatitis 50 irregular menstruation 50 thromboembolism 50 obstructive sleep apnea hypopnea 50 confusion sleepiness 50 liver enlargement hepatomegaly 50 dopamine synthesis 50 extubation 50 SHBG levels 50 chronic hemolysis 50 aneuploid cells 50 allodynia 50 growth hormone secretion 50 chorioamnionitis 50 hemodynamic measurements 50 CPAP adherence 50 Genetic variants 50 airway narrowing 50 lateral radiograph 50 fasting insulin 50 psoriatic lesions 50 hippocampal function 50 obstetric interventions 50 serum HBV DNA 50 serum BDNF 50 coronary stenosis 50 CYP#C# gene 50 epigenetic markers 50 symptom flare ups 50 bone metabolism 50 biventricular pacing 50 diurnal rhythm 50 cervical lymph nodes 50 inhibin B 50 reflux symptoms 50 serum HCV RNA 50 albumin excretion 50 IELT 50 nausea photophobia 50 hypopigmentation 50 neurologic sequelae 50 arrhythmogenic 50 impaired insulin secretion 50 telogen effluvium 50 bronchoalveolar lavage BAL 50 nonfatal MI 50 overt nephropathy 50 nifedipine 50 Neovascular AMD 50 prolactin levels 50 insomnia somnolence 50 surgically induced 50 neuronal circuits 50 recanalization 50 severe hepatic dysfunction 50 tissue oxygenation 50 c Fos 50 APOE genotype 50 GnRH agonists 50 Perfusion CT 50 angiography CTA 50 histologic examination 50 parenchymal 50 transthoracic echocardiography 50 HOMA IR 50 CLA supplementation 50 psychomotor retardation 50 gonadotropins 50 Nonspecific 50 immunohistochemical analysis 50 LVNC 50 HER2 expression 50 sensory gating 50 somnolence sleepiness 50 Prognostic factors 50 gingiva 50 Multivariate analysis 50 bullous 50 6MWD 50 atrophic 50 Suboptimal 50 cerebral autoregulation 50 cardiotoxic effects 50 #q# deletion syndrome 50 abruption 50 ventricular dysfunction 50 plexiform neurofibromas 50 coronary microvascular 50 Sonographic 50 LUTS 50 CI -#.# 50 exertional dyspnea 50 laser Doppler 50 = #.#-#.# 50 cerebral perfusion 50 Warfarin Coumadin 50 androgen depletion 50 symptom exacerbation 50 Reveal XT 50 Endothelial function 50 Genetic predisposition 50 impaired glucose metabolism 50 spontaneous bowel movements 50 thyrotropin levels 50 urinary calcium excretion 50 affective psychoses 50 Depressive symptoms 50 Logistic regression analysis 50 Calcium absorption 50 myogenic 50 pulmonary vasculature 50 clinically meaningful improvement 50 headache abdominal pain 50 noncardiovascular 50 uterus fallopian tubes 50 ischemic lesions 50 elevated prolactin 50 agitation irritability 50 chronic LBP 50 Inhibin B 50 Sleep disordered breathing 50 invasive biopsy 50 glucagon secretion 50 Visual acuity 50 Relaxation techniques 50 underwent coronary angiography 50 serum potassium levels 50 vastus lateralis 50 peri menopause 50 sigmoid 50 d dimer 50 urinary cytology 50 paroxysmal atrial fibrillation 50 cAMP signaling 50 thrombophlebitis 50 genetic polymorphism 50 MT1 MMP 50 extrapyramidal symptoms EPS 50 Inventory BPI 50 hormonal deficiencies 50 thyroxine 50 virologic failure